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Objective: Many diseases, including atherosclerosis, involve chronic inﬂammation. The master tran-
scription factor for inﬂammation is NF-kB. Inﬂammatory sites have a low extracellular pH. Our objective
was to demonstrate the effect of pH on NF-kB activation and cytokine secretion.
Methods: Mouse J774 macrophages or human THP-1 or monocyte-derived macrophages were incubated
at pH 7.0e7.4 and inﬂammatory cytokine secretion and NF-kB activity were measured.
Results: A pH of 7.0 greatly decreased pro-inﬂammatory cytokine secretion (TNF or IL-6) by J774 mac-
rophages, but not THP-1 or human monocyte-derived macrophages. Upon stimulation of mouse mac-
rophages, the levels of IkBa, which inhibits NF-kB, fell but low pH prevented its later increase, which
normally restores the baseline activity of NF-kB, even though the levels of mRNA for IkBawere increased.
pH 7.0 greatly increased and prolonged NF-kB binding to its consensus promoter sequence, especially the
anti-inﬂammatory p50:p50 homodimers. Human p50 was overexpressed using adenovirus in THP-1
macrophages and monocyte-derived macrophages to see if it would confer pH sensitivity to NF-kB ac-
tivity in human cells. Overexpression of p50 increased p50:p50 DNA-binding and in THP-1 macrophages
inhibited considerably TNF and IL-6 secretion, but there was still no effect of pH on p50:p50 DNA binding
or cytokine secretion.
Conclusion: A modest decrease in pH can sometimes have marked effects on NF-kB activation and
cytokine secretion and might be one reason to explain why mice normally develop less atherosclerosis
than do humans.
 2014 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Atherosclerosis is a chronic inﬂammatory disease [1]. Although
large atherosclerotic plaques may cause a degree of stenosis and
tissue ischaemia, the majority of clinical endpoints of atheroscle-
rotic disease, such as myocardial infarction or stroke, arise from the
exposure of the thrombogenic contents of atherosclerotic lesions to
the circulation, thus giving rise to thrombi or emboli [2]. Thus
plaque type or composition, as well as plaque size, are important. It
is generally understood that those lesions that are prone to rupture
with a weakness of the ﬁbrous cap are those that have more areas
of low extracellular pH, high lipid content, and a moreBY-NC-ND license (http://
fax: þ44 (0)118 378 6642.
om (A.B. Gerry), d.s.leake@
Ltd., 57c Milton Park, Abing-
4 (0)123 543 8614.
Published by Elsevier Ireland Ltd.inﬂammatory phenotype with the presence of large numbers of
macrophage [2].
Like other focal inﬂammatory situations, such as rheumatoid
arthritis [3] and tumours [4], atherosclerotic lesions have regions of
low extracellular pH [5e7]. The pH across atherosclerotic lesions is
heterogeneous and may vary by up to a whole pH unit, from pH 7.8
to as low as pH 6.8, presumably reﬂecting the presence of activated
macrophages in the lipid-rich areas and alkali calcium salts in the
calciﬁed areas [6]. A few studies have addressed the role of low
extracellular pH on atherogenesis, for instance, a low pH can pro-
mote the oxidation of low density lipoprotein (LDL) by macro-
phages [8], some antioxidants work less well at a lower pH [9],
oxidised LDL causes less apoptosis of macrophages at low pH [10]
and a low pH decreases cholesterol release from macrophages
[11]. Additionally, chronic acidosis in end stage chronic renal dis-
ease is associated with accelerated atherosclerosis and cardiovas-
cular morbidity and mortality [12].
Nuclear factor (NF)-kB is a transcription factor pivotal for the
development and control of inﬂammation. Dysregulation of NF-kB
signalling has been shown to play a major role in many chronic
inﬂammatory diseases, such as rheumatoid arthritis, inﬂammatory
bowel disease, psoriasis and atherosclerosis [13e16].All rights reserved.
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homodimers of p65 (RelA), p50 (NF-kB1), p52 (NF-kB2), RelB and c-
Rel. The p50 and p52 subunits are produced by processing of their
precursor molecules p105 and p100, respectively, and lack trans-
activation domains [17]. Classical NF-kB, composed of heterodimers
of p65 and p50, is a potent activator of a plethora of generally pro-
inﬂammatory cytokines, such as interleukin (IL)-6 and tumour
necrosis factor (TNF). In an inactive cell, the classical p65:p50 dimer
is held in the cytosol in an inactive state bound to its inhibitory
protein IkBa. In response to a variety of extracellular molecules,
such as lipopolysaccharide (LPS), IL-1b or TNF, IkBa is phosphory-
lated by IkB kinase (IKK) complex and targeted for degradation by
the 26S proteasome. The p65:p50 dimer is then free to translocate
to the nucleus to regulate gene expression. One of the genes it
activates is that for IkBa, which inhibits NF-kB in a negative feed-
back loop [17].
Less well known, however, is NF-kB signalling by the alternative
p50 homodimer. In contrast to p65:p50 heterodimers, p50 homo-
dimers are thought usually to be transcriptional repressors due to
p50, unlike most other Rel family members, lacking a trans-
activation domain [18,19]. p50 thus requires the formation of het-
erodimers [20] or binding with other transcriptional activators,
such as Bcl3 [21] to be transcriptionally active.
NF-kB signalling has complex roles in atherosclerosis [22e24].
Inhibition of NF-kB activation by amacrophage-restricted depletion
of IKK2 surprisingly led to an increase in atherosclerotic lesion size
and severity in LDL receptor knockout mice [25], but in another
study with these mice its myeloid-speciﬁc deﬁciency decreased
atherosclerosis [26]. An NF-kB decoy oligonucleotide inhibited
neointima formation in rats [27]. The knockdown of IKKε decreased
atherosclerosis [28], as did a cell-permeable peptide that inhibited
the nuclear import of NF-kB [29], the NF-kB inhibitor dehydrox-
ymethylepoxyquinomicin [30] and the endothelial-speciﬁc inhibi-
tion of NF-kB [31] in mice. Haemopoietic deﬁciency of the gene
encoding for p50 led to smaller, but more inﬂammatory, lesions in
mice [32].
IL-10, produced by many cell types including monocytes/mac-
rophages, is a pleiotropic cytokine that suppresses the production
of macrophage inﬂammatory proteins such as IL-6 and TNF [33,34].
IL-10 has been demonstrated to block NF-kB pro-inﬂammatory
signalling through the suppression of IKK [35] and by inducing
the expression of BCL-3, which can inhibit NF-kB activity [36]. IL-10
causes the selective induction of nuclear translocation and DNA-
binding of p50 homodimers [37].
As many chronic inﬂammatory diseases contain areas of low
extracellular pH, we have investigated the effect of pH on NF-kB
activity in macrophages. We used a pH of 7.0 because the
macrophage-rich regions of human carotid atherosclerotic plaques
contain considerable areas with this extracellular pH [6]. We have
found that reducing the extracellular pH can inhibit greatly cyto-
kine secretion in murine, but not human, macrophages. We suggest
that this inhibition of cytokine secretion in murine cells is due to
increased p50 homodimer anti-inﬂammatory signalling in
response to a low pH.
2. Methods
2.1. Materials
Unless stated otherwise all materials were obtained from Sigma
Aldrich (Poole, Dorset, U.K.) in their highest purity. RPMI, Dulbec-
co’s modiﬁed Eagle medium (DMEM), phosphate buffered saline
(PBS), foetal calf serum (FCS), Glutamax, penicillin and strepto-
mycinwere obtained from Invitrogen (Paisley, U.K.). THP-1 and J774
cells were obtained from the European Collection of Animal CellCultures (Salisbury, Wiltshire, U.K.). [g-32P]-ATP (370MBq/ml,
10 mCi/ml), polyvinylidene diﬂuoride membrane (PVDF) and pol-
y(dIedC)epoly(dIedC) was obtained from Amersham Biosciences
(Little Chalfont, Buckinghamshire, U.K.). NF-kB Gel Shift Assay
System was obtained from Promega (Southampton, Hampshire,
U.K.). Goat polyclonal antibodies for p50 (cross reactive with p105),
rabbit polyclonal antibodies to p50, p65 or IkBa and actin, donkey
anti-goat IgGehorseradish peroxidase (HRP) and supershift anti-
bodies were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, U.S.A.). Donkey anti-goat IgGeﬂuorescein isothiocyanate (FITC)
was obtained from AbD Serotec (Oxford, U.K.). Lymphoprep was
obtained from Axis-Shield (Oslo, Norway).
2.2. Cell culture
Human peripheral blood monocytes were isolated from the
blood of healthy volunteers using Lymphoprep, as described pre-
viously [38]. This project has been reviewed by the University of
Reading Research Ethics Committee and has been given a favour-
able opinion for conduct. Monocytes were cultured in RPMI sup-
plemented with 10% (v/v) human serum containing 2 mM
Glutamax, penicillin (20 IU/ml) and streptomycin (20 mg/ml) for 7e
10 days to differentiate into human monocyte-derived macro-
phages (HMDM). The J774 murine macrophage-like cell line was
cultured in DMEM containing glucose (1 g/l), sodium pyruvate and
pyridoxine, supplemented with 10% FBS (v/v), 2 mM Glutamax,
penicillin (20 IU/ml), streptomycin (20 mg/ml) and amphotericin B
(0.95 mg/ml) andmaintained at 37 C in a humidiﬁed 95% air/5% CO2
atmosphere. THP-1 human monocytes were cultured in RPMI
containing 2mM glutamine, 10% FBS (v/v), penicillin (20 IU/ml) and
streptomycin (20 mg/ml). THP-1 cells were differentiated prior to
treatment by phorbol 12-myristate 13-acetate (PMA; 100 ng/ml) for
48 h. Culture medium pH was modiﬁed by the addition of an
appropriate volume of 5 M HCl. These ﬂasks of medium were
allowed to equilibrate at 37 C in a humidiﬁed 95% air/5% CO2 at-
mosphere for at least four days before the pH was determined.
Culture medium pH was determined rapidly before, after and
during incubation with cells using a Mettler-Toledo MP220 pH
meter with an Inlab 423 microelectrode. The pH meter was cali-
brated using prewarmed standards with the required meter tem-
perature manual adjustments.
2.3. Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared using nuclei lysis solution and
the electrophoretic mobility shift assay was performed using the
NF-kB Gel Shift Assay System according to the manufacturer’s in-
structions. Supershift reactions were carried out by pre-incubation
of nuclear extracts with an excess of p50 antibody (goat polyclonal
IgG raised against a peptide mapping inside the nuclear localisation
sequence) and p65 antibody (goat polyclonal IgG mapping within
the amino terminal domain). Semi-quantitative analysis was per-
formed with Quantity One software (Bio-Rad).
2.4. Adenovirus-infection studies
Recombinant adenoviruses were produced from constructs
expressing p50 (AdV-p50) or EGFP (AdV-EGFP) generously pro-
vided by Dr Nicole Horwood (Imperial College London, U.K.) and Dr
Katrina A. Bicknell (Pharmacy, University of Reading, U.K.),
respectively. PMA-differentiated THP-1 macrophages or serum-
differentiated primary human macrophages were incubated for
72 h with either no virus, AdV-p50 or AdV-EGFP at a multiplicity of
infection (MOI) of 100 plaque-forming units of each virus per cell.
ThisMOI was determined as sufﬁcient to achieve as high as possible
Fig. 1. Effect of pH on TNF secretion by macrophages. J774 (A) or THP-1 macrophages
(B) were incubated at pH 7.4 or 7.0 for 24 h before treatment with or without IL-10
(20 ng/ml) for 2 h followed by LPS (100 pg/ml) for 2 h. The concentration of TNF
was then measured in the medium by ELISA. The white and black bars show the data in
the absence or presence of IL-10, respectively. *P < 0.05.
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ing ﬂuorescent microscopy. Culture mediumwas then replaced and
the cells treated as required.
2.5. Confocal microscopy
PMA-differentiated THP-1macrophages or serum-differentiated
primary human macrophages were grown on glass coverslips
before incubationwith or without adenovirus. The culture medium
was replaced and cells treated as stated in the ﬁgure legends. The
cells were then washed three times with PBS, ﬁxed and per-
meabilised with 4% (w/v) paraformaldehyde in PBS at room tem-
perature for 15 min and 100% methanol at 20 C for 10 min. They
were washed twice with PBS containing 1% (w/v) BSA and 0.01%
sodium azide. The cells were then incubated with goat polyclonal
anti-p50 IgG (5 mg/ml) for 1 h at room temperature, washed four
times with PBS containing 1% (w/v) BSA and 0.01% sodium azide
and incubated with FITC-or Cy3-conjugated donkey anti-goat IgG
(5 mg/ml) and propidium iodide for 1 h at room temperature.
Coverslips were then mounted on the slides using VECTASHIELD
mounting medium (Vector Laboratories, U.K.) and sealed with nail
varnish before storage at 4 C in the dark. Microscope slides were
analysed using a Leica TCS NT confocal microscope (Leica Micro-
systems) using a 63 immersion objective lens. Semi-
quantiﬁcation was performed using Leica confocal software.
2.6. Western blotting
Whole cell lysates were prepared as described previously [39].
Protein content was estimated as described by Bradford [40]. Pro-
tein extracts (20 mg of protein) were separated by SDS-PAGE. Pro-
teins were electrotransferred onto a PVDF membrane using a semi-
dry blotter (BioRad, Hertfordshire, U.K.). Detection of p50/p105
(1:400) and actin (1:1000) was achieved using goat polyclonal IgGs
followed by incubationwith a donkey anti-goat IgGeHRP (1:4000).
Detection was completed by enhanced chemiluminescence
(Amersham Biosciences, Little Chalfont, Buckinghamshire, UK).
2.7. Cytokine ELISA
Culture medium was collected following incubation of cells at
the required pH in the absence or presence of LPS (100 pg/ml) for
the stated times. Cell debris was removed by centrifugation. Sam-
ples were assayed for TNF or IL-6 by Quantikine ELISA as stated in
themanufacturer’s instructions (R&D Systems,Minneapolis, U.S.A.).
2.8. Statistical analysis
Where indicated graphs represent the mean  S.E.M. of the
mean of n independent experiments. Statistical analysis was per-
formed using ANOVA or the Student’s paired t-test to determine
differences between observations. Differences between observa-
tions were deemed to be signiﬁcant when P < 0.05.
3. Experimental results
3.1. Effects of pH on cytokine secretion by macrophages
As atherosclerotic lesions are known to have a low extracellular
pH [6], we investigated the effects of a moderate reduction of pH on
the secretion of the inﬂammatory cytokine TNF by macrophages.
LPS greatly increased the secretion of TNF by murine J774 macro-
phages at pH 7.4 (Fig. 1A). TNF secretion was similar in the absence
of LPS at pH 7.0 and 7.4, but TNF secretion in the presence of LPS
was reduced by 85% at pH 7.0 compared to pH 7.4. We have shownpreviously that incubation of J774 macrophages for 24e48 h at pH
7.0 is not toxic to the cells [10]. LPS increased greatly the secretion
of TNF by human THP-1 macrophages, but the increase was com-
parable at pH 7.4 and 7.0 (Fig. 1B). Similarly to the effect of low pH,
the anti-inﬂammatory cytokine IL-10 inhibited LPS-induced cyto-
kine secretion by J774 cells, but not by THP-1 cells (Fig. 1).
3.2. Effects of pH on IkBa levels in macrophages
To explore the mechanisms of the effects of low pH on cytokine
secretion by macrophages, we investigated the effect of pH on the
levels of IkBa protein and mRNA. NF-kB is the master transcription
factor for inﬂammatory cytokine production and is normally
inhibited by the protein IkBa. When cells are stimulated, IkBa is
phosphorylated, polyubiquitinated and degraded by proteasomes,
enablingNF-kB toenter thenucleus and increase the transcriptionof
inﬂammatory genes. We therefore measured the levels of IkBa
protein by Western blots in macrophages stimulated by TNF at
normal and low pH. At pH 7.4, the levels of IkBa decreased within
10 min, reached the lowest level at 20 min and then started to in-
crease, returning tonormal at 60min (Fig. 2A). AtpH7.0, the levels of
IkBa decreased within 10e20 min, but did not increase thereafter.
3.3. Effects of pH on IkBa mRNA levels in macrophages
To explore themechanism for the failure of IkBa to increase after
its fall at low pH, we measured the level of mRNA encoding for this
Fig. 2. Effect of pH on the levels of IkBa protein and mRNA levels. J774 macrophages were incubated for 24 h at pH 7.4 (white bars) or pH 7.0 (black bars) and then at these pH values
for up to 60 min with TNF (25 ng/ml). (A) Shows the normalised levels of IkBa protein relative to actin measured by Western blots. The mean  S.E. of three independent ex-
periments is shown. *P < 0.05 for the difference between pH 7.4 and 7.0 (Student’s paired t-test). (B) Shows the normalised levels of mRNA for IkBa relative to b-actin. The
mean  S.E. of three independent experiments is shown. #P < 0.05 for the difference between pH 7.4 and 7.0 (ANOVA).
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continued to increase up to 30min, as the NF-kB turned on the gene
for its own inhibitor (Fig. 2B). There was also an increase in the
mRNA for IkBa at pH 7.0 (which was somewhat greater than that at
pH 7.4). The failure of IkBa protein to increase after its initial fall at
pH 7.0 was therefore not due to a failure of its mRNA to increase and
might indicate that the newly synthesised IkBa protein was
degraded as rapidly as it was synthesised.Control IL-10 TNF TNF + IL-10
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B: THP-1 macrophages3.4. Effects of low pH on p50/p105 levels
We used confocal microscopy to further probe the mechanisms
involved by demonstrating that in the presence of either TNF or IL-
10, or both together, there was an increase in the nuclear levels of
p50/p105 (the antibody recognises both p50 and p105) in J774 cells
at pH 7.0, but not at pH 7.4 (Fig. 3). There were no effects of pH on
the nuclear levels of p50/p105 in the THP-1 cells (Fig. 3). These
observations suggest that a low pH may increase the entry of p50
into the nuclei of J774 mouse macrophages and increase the
binding of the inhibitory p50 homodimer to DNA, thus inhibiting
cytokine secretion.Control IL-10 TNF TNF + IL-10
N
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ar
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/p
10
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Fig. 3. Effects of pH on the levels of p50/p105 in macrophages. J774 (A) or THP-1 (B)
cells were incubated for 24 h at 7.4 (white bars) or 7.0 (black bars) before treatment for
90 min with IL-10 (10 ng/ml), TNF (25 ng/ml), both together or in the absence of added
cytokines (control). The nuclear levels of p50/p150 protein (the antibody recognises
both p50 and p105), relative to the control at pH 7.4, were quantiﬁed by confocal
microscopy. *P < 0.05 compared to pH 7.4.3.5. Effects of low pH on NF-kB DNA-binding
We further investigated the effects of pH on NF-kB activity by
assessing the binding of this transcription factor from nuclear ex-
tracts of mouse J774 macrophages to a consensus sequence oligo-
nucleotide for the NF-kB promoter. Two speciﬁc bands were seen
(Fig. 4A). The upper band corresponds to the binding of the p65:p50
heterodimer to the consensus DNA sequence and the lower band to
the binding of the p50:p50 homodimer. A speciﬁc competitor
(nonlabelled NF-kB consensus oligonucleotide) prevented the
binding of the dimers to the radioactive oligonucleotide, but a
nonspeciﬁc oligonucleotide (nonlabelled oct1 oligonucleotide) did
not. Supershift analysis using an antibody to p50 retarded the
mobility of both bands, whereas an antibody to p65 retarded the
migration of only the top band, as expected. TNF stimulation of J774
mouse macrophages at pH 7.4 caused a transient increase in NF-kB
p65:p50 DNA-binding, which peaked at 2 h (Fig. 4B). Reducing the
extracellular pH to 7.0 led to an increased extent and prolongation
Fig. 4. Electrophoretic mobility shift assay of NF-kB binding to DNA to macrophages. (A) J774 cells were incubated for 24 h at 7.4 or 7.0 before treatment with TNF (25 ng/ml) for the
indicated times. Nuclear extract was prepared and analysed for NF-kB binding by EMSA. Supershift analysis at 2 h at pH 7.4 using antibodies to p50 (SS p50) or p65 (SS p65)
conﬁrmed the presence of p50:p50 and p65:p50. SC: speciﬁc competitor (excess nonlabelled NF-kB consensus oligonucleotide). NSC: nonspeciﬁc competitor (excess nonlabelled
nonrelated oligonucleotide). (B) The binding of p65:p50 was semi-quantiﬁed at pH 7.4 and (white bars) and 7.0 (black bars). The bars represent the mean  S.E. of three inde-
pendent experiments. There was a signiﬁcant difference between the binding at pH 7.4 and 7.0 (P < 0.05; ANOVA) and between individual pH values (*P < 0.05; Student’s paired t-
test). (C) THP-1 cells were incubated for 24 h at 7.4 or 7.0 before treatment with TNF (25 ng/ml) for 2 h. Nuclear extract was prepared and analysed for NF-kB binding by EMSA. The
band above the p65:p50 band may possibly be p65:p65 homodimers. These results are representative of three independent experiments.
A.B. Gerry, D.S. Leake / Atherosclerosis 233 (2014) 537e544 541in p65:p50 DNA-binding for at least 24 h, which was even more
marked for p50:p50 binding.
TNF increased NF-kB binding to DNA with the human THP-1
macrophages, but reducing the extracellular pH from 7.4 to 7.0Fig. 5. Effects of overexpression of p50. THP-1 human macrophages or HMDM were incub
expressed in cells incubated with Adv-p50, but not in cells incubated with AdV-EGFP or with
(in yellow) was expressed in THP-1 macrophages following incubation with AdV-p50, but no
taken up by the cells (in green). The nuclei are shown by PI staining (in red). The insets show
but not the bottom one. The upper cell contains abundant p50 (yellow), whereas the lower
24 h at 7.4 or 7.0. Nuclear extracts were prepared and analysed for NF-kB binding by EM
antibody to p50 (SS p50) conﬁrmed the presence of much greater amounts of p50:p50 in
consensus oligonucleotide). NSC: nonspeciﬁc competitor (excess nonlabelled nonrelated oli
reader is referred to the web version of this article.)did not increase p65:p50 or p50:p50 DNA-binding (Fig. 4C), in
contrast to the J774 mouse macrophages. A low extracellular pH
may possibly have caused an increase in p65:p65 DNA-binding in
the THP-1 cells (Fig. 4C).ated with adenovirus containing p50 or EGFP. (A) Western blots showing that p50 is
out virus. Actin was used as a loading control. (B) Confocal microscopy showed that p50
t with AdV-EGFP or without virus, even though both AdV-p50 and AdV-EGFP had been
two cells (nuclei shown in red), the upper one of which had taken up AdV-p50 (green)
cell does not. (C) THP-1 or human monocyte-derived macrophages were incubated for
SA. Supershift analysis of human monocyte-derived macrophages at pH 7.0 using an
the cells incubated with AdV-p50. SC: speciﬁc competitor (excess nonlabelled NF-kB
gonucleotide). (For interpretation of the references to colour in this ﬁgure legend, the
A.B. Gerry, D.S. Leake / Atherosclerosis 233 (2014) 537e5445423.6. Effect of p50 overexpression on NF-kB activity
We investigated whether overexpressing p50 in THP-1 human
macrophages or human-monocyte derived macrophages would
confer the same pH sensitivity to NF-kB activity in human cells as
was seen in mouse macrophages. Infection of THP-1 macrophages
or HMDM with AdV-p50, but not AdV-EGFP, led to a marked in-
crease in p50 protein expression (Fig. 5A). Confocal microscopy also
showed an increase in expression of p50 in THP-1 cells incubated
with AdV-p50 (Fig. 5B). Two cells are shown in a circle in Fig. 5B.
The upper cell has been infected by the adenovirus, as shown by
intense green ﬂuorescence, whereas the lower cell was not been
infected to any great extent. The upper cell shows intense ﬂuo-
rescence corresponding to p50 staining, whereas the bottom cell
does not. Overexpression of p50 in THP-1 or human monocyte-
derived macrophages led to an increase in constitutive p50
homodimer DNA-binding without increasing p65:p50 DNA-
binding at pH 7.4 (Fig. 5C). Incubation of HMDM at pH 7.0
following AdV-p50 infection led to an increase in p50 homodimer
DNA-binding, with little increase in p65:p50 DNA-binding.
Overexpression of p50 in THP-1 macrophages inhibited TNF
secretion induced by LPS at 24 h by about 50% (P < 0.05) and IL-6
secretion by about 85% (P < 0.05) at pH 7.4 or 7.0 (Fig. 6). The
control adenovirus had little or no effect (Fig. 6). Low extracellular
pH (Fig. 6) or IL-10 (results not shown) had little effect on pro-
inﬂammatory cytokine secretion. Similar results were obtained
with 4 h incubation with LPS (results not shown). Fig. 6B demon-
strates that reducing the pH from 7.4 to 7.0 did not affect TNF or IL-6
secretion by HMDM in response to LPS. AdV-p50, but not AdV-
EGFP, had a tendency to inhibit LPS-induced TNF and IL-6 secre-
tion in HMDM, but the inhibition was only modest.Fig. 6. Effects of overexpression of p50 on cytokine secretion by macrophages. (A) THP-1
containing the gene for p50 (black bars) or left untreated (white bars). The cells were then in
these pH values. The medium was assayed for TNF or IL-6 by ELISA. *P < 0.05.4. Discussion
Atherosclerotic lesions, as well as other sites of chronic
inﬂammation, such as rheumatoid joints and tumours, have areas
of low extracellular pH [3,4,6]. We observed that pro-inﬂammatory
cytokine secretion stimulated by LPS was far less at pH 7.0 than at
pH 7.4 for mouse J774 macrophages, but not for human monocyte-
derived macrophages or human THP-1 macrophages (Figs. 1 and 6).
It has been observed previously that J774 cells [41,42] and mouse
peritoneal macrophages [43] secrete less TNF at low pH, but human
monocyte-derived macrophages, THP-1 cells [44] and human
monocytes [45] secrete more IL-1b at low pH. Our ﬁndings are in
agreement with those of Grabowski et al. [42] using J774 macro-
phages, but extend their ﬁndings to look at the levels of IkBa over
time and the binding of p65:p65 and p65:p50 dimers to the of NF-
kB promoter.
After stimulation, the levels of IkBa protein, the inhibitor of NF-
kB, in the mouse macrophages decreased at both pH 7.4 and 7.0, as
it was degraded, and returned back to normal within 1 h at pH 7.4,
but remained depressed at pH 7.0 (Fig. 2A). The mouse macro-
phages increased their levels of mRNA for IkBa at both pH 7.4 and
7.0 (Fig. 2B). This observation would be consistent with the mRNA
for IkBa being translated at pH 7.0, but the IkBa protein being
continuously phosphorylated by IKK2, polyubiquitinated and
degraded by proteasomes.
There was an increase in nuclear localisation of p50/p105 (the
antibody we used recognised both proteins) in the mouse cells, but
not in the humanTHP-1 cells, incubated with the pro-inﬂammatory
cytokine TNF or the anti-inﬂammatory cytokine IL-10, or both
together, at pH 7.0, but not at pH 7.4 (Fig. 3). IL-10 has been shown
previously to increase selectively the nuclear localisation of p50cells or (B) HMDM were infected with control adenovirus (grey bars) or adenovirus
cubated at pH 7.4 or 7.0 for 24 h and thenwith or without (C) LPS (100 pg/ml) for 24 h at
A.B. Gerry, D.S. Leake / Atherosclerosis 233 (2014) 537e544 543homodimers and this might help to explain why it is anti-
inﬂammatory [37]. The reason why TNF also increased the level
of p50 in the nucleus might have been because it induced the entry
of pro-inﬂammatory p65:p50 heterodimers into the nucleus. There
was a marked increase in the intensity and duration of NF-kB
binding to a consensus oligonucleotide for the promoter of genes
controlled by this transcription factor at low pH, especially for the
p50:p50 homodimer (Fig. 4A and B), but no increase in p50:p50
homodimer or p65:p50 heterodimer binding at low pH in THP-1
macrophages (Fig. 4C). The p50:p50 homodimer has no trans-
activation domain [46,47] and thus may block the activation of NF-
kB by p65:p50 dimers. This may explain why the secretion of pro-
inﬂammatory cytokines was reduced at low pH in the mouse cells.
Bellocq et al. [48] noted the low pH induced an increase in p65:p50
DNA-binding and reporter gene activity in rat macrophages at 2 h,
but did not comment on the increase in p50 homodimer DNA-
binding. They showed an increase in TNF secretion at low pH,
which is contrary to our results withmousemacrophages and other
data with rabbit alveolar macrophages [49].
We overexpressed p50 in human macrophages to see if it would
confer the same pH sensitivity to NF-kB activity in human cells as
was present in mouse macrophages. Overexpression of p50 in hu-
man THP-1 macrophages using an adenovirus inhibited pro-
inﬂammatory cytokine secretion considerably (Fig. 6A). We
observed that lower transfection efﬁciencies, using lipid-mediated
or electroporation techniques, had varied and often opposing ef-
fects on the cytokine secretion proﬁle of the macrophages (Gerry
and Leake, unpublished observations). p50 has a higher afﬁnity for
p65 than itself [50] and so it may be necessary to increase p50
levels substantially to increase p50:p50 homodimer formation.
Overexpression of p50 in humanTHP-1 or HMDMdid not, however,
lead to the appearance of an inhibitory effect of pH on cytokine
secretion at low pH (Fig. 6). Lowering the pH from 7.4 to 7.0, in
either the presence or absence of p50 overexpression, had no effect
on cytokine secretion in the humanmacrophages, in contrast to the
mouse macrophages (Fig. 1).
A low extracellular pH within atherosclerotic lesions might
possibly have different effects in mice and humans, increasing
the activity of p50:p50 homodimers in mice but not in humans.
This might decrease the expression of pro-inﬂammatory cyto-
kines in mice and may be one factor to help explain why
atherosclerosis is less severe in mice (unless genetically modi-
ﬁed) than in humans.
IL-10 is produced by many cell types and is generally
considered to be anti-inﬂammatory [34,51], as it suppresses the
production of inﬂammatory cytokines, such as IL-6 and TNF. IL-
10 has been shown to block nuclear translocation of p65, but
to induce nuclear translocation of p50 and to increase the
binding of p50:p50 homodimers to DNA [37]. We therefore
tested the effects of IL-10 on pro-inﬂammatory cytokine secre-
tion. Interestingly, IL-10 and low pH inhibited pro-inﬂammatory
cytokine secretion in mouse J774 macrophages, but neither
inhibited pro-inﬂammatory cytokine secretion in human THP-1
macrophages, regardless of whether or not p50 had been over-
expressed in the THP-1 cells (Fig. 1 and results not shown). The
reason for the different behaviour of the IL-10 in the two types of
macrophages is unknown.
A moderate reduction of pH greatly decreased inﬂammatory
cytokine secretion in mouse, but not in human macrophages. The
DNA-binding activity of NF-kB, especially for p50:p50 homo-
dimers, was greatly increased and prolonged at low pH in the
mouse macrophages. The effects of pH on inﬂammation in
atherosclerosis are complex because, as well as regulating in-
ﬂammatory genes, NF-kB is involved in the resolution of
inﬂammation [52,53].Funding
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